1. Di Sciascio G, Riva MA. Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatr Dis Treat. 2015;11:2635–47.
2. Casey AB, Canal CE. Classics in chemical neuroscience: aripiprazole. ACS Chem Neurosci. 2017;8(6):1135–46.
3. Abdelbary AA, Elshafeey AH, El-Nabarawi M, Elassasy A, Li X, Jasti B. Comparative in vivo evaluation of aripiprazole coprecipitate, nanoparticles and marketed tablets in healthy human volunteers and in vitro-in vivo correlation. Curr Trends Biotechnol Pharm. 2011;5(4):1397–409.
4. Silki, Sinha VR. Enhancement of in vivo efficacy and oral bioavailability of aripiprazole with solid lipid nanoparticles. AAPS PharmSciTech. 2018;19(3):1264–73.
5. Brittain HG. Aripiprazole: polymorphs and solvatomorphs. In: Brittain HG, editor. Profile of drug substances, excipients and related metodology, vol. 37. Amsterdam: Esevier; 2012. p. 1–29.